-
Guest, the 'News in Brief' for the week beginning 16th January 2023 is here.Dismiss Notice
-
Welcome! To read the Core Purpose and Values of our forum, click here.Dismiss Notice
Clinical trial: Temelimab as a disease-modifying therapy in patients with neuropsychiatric symptoms in Long COVID (or PASC)
Discussion in 'Long Covid news' started by Braganca, Nov 17, 2022.